# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Alex Kramm maintains CBRE Group (NYSE:CBRE) with a Neutral and lowers the price target from $100 to $95.
The partnership offers a comprehensive, turnkey solution to surgeons and institutions looking to expand their orthopedic ASC fo...
Tesla's decision to lay off approximately 500 employees from its Supercharging team as part of its global restructuring eff...
A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expe...
CBRE Group (NYSE:CBRE) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.68 by 14....